[Investigation about an influence of physostigmine on schizophrenic symptoms (author's transl)].
D000328:Adult; D002986:Clinical Trials as Topic; D003863:Depression / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010830:Physostigmine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D013223:Statistics as Topic
D009388:Neostigmine; D010830:Physostigmine
Zur Frage der Beeinflussung schizophrener Symptome durch Physostigmin